• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】35375

【品名】 

【CA登记号】

【 分 子 式 】C52H84N4O14

【 分 子 量 】989.25752

【元素组成】C 63.14% H 8.56% N 5.66% O 22.64%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(VII)

The acetylation of clarithromycin (I) with acetic anhydride gives the diacetate (II), which is acylated with CDI yielding the 12-O-(imidazolylcarbonyl compound (III). The cyclization of (III) with ethylenediamine (IV) affords the cyclic carbamate (V), which is alkylated by reductocondensation with pyridine-3-carbaldehyde (VI) and NaBH(OAc)3 to give the secondary amine (VII). The methylation of this amine with formaldehyde and NaBH(OAc)3 yields the corresponding tertiary amine (VIII), which is treated with aqueous HCl to provide the descladinosyl compound (IX). Finally, this compound is acylated with 2-(2-pyridyl)acetic acid (X) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (WSC), and deacetylated with methanol to afford the target compound.

1 Tanikawa, T.; Akashi, T.; Manaka, A.; Suzuki, K.; Asaka, T.; Adachi, T.; Ishii, T.; Sugiyama, H.; Kashimura, M.; Saito, H.; Morimoto, S.; Structure activity studies leading potent acyclides: 3-O-Acyl-5-O-desosaminylerythronolide 11,12-carbamates. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2159.
2 Ishii, T.; Tanikawa, T.; Matsuura, A.; Sugimoto, T.; Asaka, T.; Kashimura, M. (Taisho Pharmaceutical Co., Ltd.); Erythromycin A derivs.. EP 0945459; WO 9823628 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35358   C39H71NO12 详情 详情
(II) 35359   C43H75NO14 详情 详情
(III) 35360   C47H75N3O14 详情 详情
(IV) 14754 ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine 107-15-3 C2H8N2 详情 详情
(V) 35361   C46H79N3O14 详情 详情
(VI) 35374 5,6-dihydro-3-pyridinecarbaldehyde C6H7NO 详情 详情
(VII) 35375   C52H84N4O14 详情 详情
(VIII) 35376   C53H86N4O14 详情 详情
(IX) 35377   C43H70N4O10 详情 详情
(X) 35366 2-(2-pyridinyl)acetic acid 16179-97-8 C7H7NO2 详情 详情
Extended Information